Precept Management’s Dentsply Sirona XRAY Stock Holding History

Precept Management’s Portfolio XRAY Stock Details XRAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-19,500	Closed	-$1.26M	–	69
2017 Q2	$1.26M	Buy	+19,500	New	+$1.23M	0.78%	39

Other funds holding XRAY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Precept Management's XRAY Position: Q3 2017 in Review

Precept Management sold out of Dentsply Sirona (XRAY) in Q3 2017, closing a stake of 19,500 shares — an estimated $1.26M sold.

Precept Management first reported a position in XRAY in Q2 2017 and held it in 1 quarter. The position peaked at $1.26M in Q2 2017. 536 funds tracked by Wall St. Rank hold XRAY as of Q3 2017.

Precept Management reported no remaining Dentsply Sirona position as of Q3 2017 after selling out during the quarter.
Precept Management sold 19,500 Dentsply Sirona shares in Q3 2017, an estimated $1.26M.
Precept Management first reported a position in Dentsply Sirona in Q2 2017 and held it in 1 quarter.
Precept Management's Dentsply Sirona position peaked at $1.26M in Q2 2017.
536 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2017.

Based on Precept Management's 13F filing for Q3 2017, filed 14 Nov 2017.